A Stenotrophomonas maltophilia Strain Evades a Major Caenorhabditis elegans Defense Pathway
Stenotrophomonas maltophiliais a ubiquitous bacterium and an emerging nosocomial pathogen. This bacterium is resistant to many antibiotics, associated with a number of infections, and a significant health risk, especially for immunocompromised patients. Given thatCaenorhabditis elegansshares many conserved genetic pathways and pathway components with higher organisms, the study of its interaction with bacterial pathogens has biomedical implications.S. maltophiliahas been isolated in association with nematodes from grassland soils, and it is likely thatC. elegansencounters this bacterium in nature. We found that a localS. maltophiliaisolate, JCMS, is more virulent than the otherS. maltophiliaisolates (R551-3 and K279a) tested. JCMS virulence correlates with intestinal distension and bacterial accumulation and requires the bacteria to be alive. Many of the conserved innate immune pathways that serve to protectC. elegansfrom various pathogenic bacteria also play a role in combatingS. maltophiliaJCMS. However,S. maltophiliaJCMS is virulent to normally pathogen-resistant DAF-2/16 insulin-like signaling pathway mutants. Furthermore, several insulin-like signaling effector genes were not significantly differentially expressed betweenS. maltophiliaJCMS and avirulent bacteria (Escherichia coliOP50). Taken together, these findings suggest thatS. maltophiliaJCMS evades the pathogen resistance conferred by the loss of DAF-2/16 pathway components. In summary, we have discovered a novel host-pathogen interaction betweenC. elegansandS. maltophiliaand established a new animal model with which to study the mode of action of this emerging nosocomial pathogen.